Cargando…
The prognostic impact of lead times in colorectal cancer patients undergoing cytoreductive surgery and HIPEC
BACKGROUND: National lead time goals have been implemented across Sweden to standardize and improve cancer patient care. However, the prognostic impact of lead times has not yet been studied in patients with colorectal cancer and peritoneal metastases scheduled for cytoreductive surgery and hyperthe...
Autores principales: | Jansson, Ylva, Graf, Wilhelm, Ghanipour, Lana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484226/ https://www.ncbi.nlm.nih.gov/pubmed/36117176 http://dx.doi.org/10.1186/s12957-022-02765-1 |
Ejemplares similares
-
Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC
por: Graf, Wilhelm, et al.
Publicado: (2019) -
Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
por: Spiliotis, J. D., et al.
Publicado: (2014) -
Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer
por: Rozich, Noah S., et al.
Publicado: (2021) -
Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases
por: Enblad, Malin, et al.
Publicado: (2019) -
The impact of urological resection and reconstruction on patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Tan, Grace Hwei Ching, et al.
Publicado: (2018)